Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades
Globus Medical (NYSE: GMED) has announced two significant product launches in its anterior spine portfolio: the COHERE™ ALIF Spacer and Modulus™ ALIF Blades.
The COHERE ALIF Spacer is the first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion surgery, featuring proprietary porous surface technology for bone in-growth while maintaining imaging and mechanical properties. The technology combines PEEK's stiffness and radiolucency with osseointegration potential.
The Modulus ALIF Blades extend the Modulus ALIF Spacer portfolio by offering different fixation options and improved procedural efficiency through immediate anchoring blade fixation following interbody spacer placement. This innovation reduces the number of surgical steps and instruments needed, allowing for a more minimally invasive approach.
Globus Medical (NYSE: GMED) ha annunciato due lanci di prodotto significativi nel suo portafoglio di spine anteriori: il COHERE™ ALIF Spacer e le Modulus™ ALIF Blades.
Il COHERE ALIF Spacer è il primo spacer intersomatico in Porous PEEK™ per la chirurgia di fusione intersomatica lombare anteriore, dotato di una tecnologia di superficie porosa proprietaria per favorire la crescita ossea mantenendo le proprietà di imaging e meccaniche. Questa tecnologia combina la rigidità e la radiolucenza del PEEK con il potenziale di osteointegrazione.
Le Modulus ALIF Blades ampliano il portafoglio del Modulus ALIF Spacer offrendo diverse opzioni di fissaggio e una maggiore efficienza procedurale grazie al fissaggio immediato delle lame di ancoraggio dopo il posizionamento dello spacer intersomatico. Questa innovazione riduce il numero di passaggi chirurgici e strumenti necessari, consentendo un approccio più minimamente invasivo.
Globus Medical (NYSE: GMED) ha anunciado dos lanzamientos de productos significativos en su cartera de columna anterior: el COHERE™ ALIF Spacer y las Modulus™ ALIF Blades.
El COHERE ALIF Spacer es el primer espaciador intersomático de Porous PEEK™ para cirugía de fusión intersomática lumbar anterior, que cuenta con una tecnología de superficie porosa patentada para el crecimiento óseo mientras mantiene las propiedades de imagen y mecánicas. La tecnología combina la rigidez y radiolucidez del PEEK con el potencial de osteointegración.
Las Modulus ALIF Blades amplían la cartera de Modulus ALIF Spacer al ofrecer diferentes opciones de fijación y una mayor eficiencia del procedimiento a través de un anclaje inmediato de las cuchillas de fijación tras la colocación del espaciador intersomático. Esta innovación reduce el número de pasos quirúrgicos e instrumentos necesarios, permitiendo un enfoque más mínimamente invasivo.
글로부스 메디컬 (NYSE: GMED)은 전방 척추 포트폴리오에서 두 가지 중요한 제품 출시를 발표했습니다: COHERE™ ALIF Spacer와 Modulus™ ALIF Blades.
COHERE ALIF Spacer는 전방 요추 간섭 융합 수술을 위한 최초의 Porous PEEK™ 간섭 스페이서로, 뼈 성장 촉진을 위한 독점적인 다공성 표면 기술을 특징으로 하며 이미징 및 기계적 특성을 유지합니다. 이 기술은 PEEK의 강성과 방사선 투과성을 뼈 통합 가능성과 결합합니다.
Modulus ALIF Blades는 Modulus ALIF Spacer 포트폴리오를 확장하여 다양한 고정 옵션을 제공하고 간섭 스페이서 배치 후 즉각적인 고정 블레이드 고정을 통해 절차 효율성을 향상시킵니다. 이 혁신은 필요한 수술 단계와 도구의 수를 줄여 보다 최소 침습적인 접근 방식을 가능하게 합니다.
Globus Medical (NYSE: GMED) a annoncé deux lancements de produits importants dans son portefeuille de colonne antérieure : le COHERE™ ALIF Spacer et les Modulus™ ALIF Blades.
Le COHERE ALIF Spacer est le premier espaceur intersomatique en Porous PEEK™ pour la chirurgie de fusion intersomatique lombaire antérieure, doté d'une technologie de surface poreuse propriétaire favorisant la croissance osseuse tout en maintenant les propriétés d'imagerie et mécaniques. Cette technologie allie la rigidité et la radiolucidité du PEEK au potentiel d'ostéo-intégration.
Les Modulus ALIF Blades étendent le portefeuille du Modulus ALIF Spacer en offrant différentes options de fixation et en améliorant l'efficacité procédurale grâce à une fixation immédiate des lames d'ancrage après le placement de l'espaceur intersomatique. Cette innovation réduit le nombre d'étapes chirurgicales et d'instruments nécessaires, permettant une approche plus minimalement invasive.
Globus Medical (NYSE: GMED) hat zwei bedeutende Produkteinführungen in seinem anterioren Wirbelsäulenportfolio angekündigt: den COHERE™ ALIF Spacer und die Modulus™ ALIF Blades.
Der COHERE ALIF Spacer ist der erste interbody Spacer aus Porous PEEK™ für die anterioren lumbalen Interbody-Fusionsoperationen und verfügt über eine proprietäre poröse Oberflächentechnologie, die das Knochenwachstum fördert und gleichzeitig die Bildgebungs- und mechanischen Eigenschaften aufrechterhält. Diese Technologie kombiniert die Steifigkeit und Radioluzidität von PEEK mit dem Potenzial zur Osteointegration.
Die Modulus ALIF Blades erweitern das Portfolio des Modulus ALIF Spacers, indem sie verschiedene Fixierungsoptionen anbieten und die Verfahrenseffizienz durch sofortige Verankerung der Blades nach der Platzierung des interbody Spacers verbessern. Diese Innovation reduziert die Anzahl der erforderlichen chirurgischen Schritte und Instrumente und ermöglicht einen minimalinvasiveren Ansatz.
- First-to-market Porous PEEK technology for ALIF surgery
- Enhanced surgical efficiency through reduced procedural steps
- Expanded product portfolio addressing diverse surgical needs
- Innovation in minimally invasive surgical approaches
- None.
Insights
Globus Medical's announcement of two new surgical implants marks a strategic expansion of their Advanced Materials Science portfolio for spinal fusion surgeries. The COHERE ALIF Spacer introduces their proprietary Porous PEEK technology to the anterior lumbar fusion market, potentially addressing a significant clinical need for implants that combine the mechanical properties of PEEK with enhanced bone integration capabilities.
The reference to "enhanced clinical outcomes" with the cervical version of this technology suggests Globus is building on previously demonstrated success, strategically expanding application across different spinal regions. Meanwhile, the Modulus ALIF Blades complement their existing interbody spacer system by adding procedural efficiencies and potentially reducing complications through minimized instrument passes near vascular structures.
From an industry perspective, these innovations align with the broader spine surgery trend toward less invasive approaches and improved integration between implants and instrumentation. The expert endorsements from prominent spine surgeons (Dr. Phillips from Rush University and Dr. Kwon from OrthoCarolina) provide clinical validation that strengthens market positioning.
While no specific financial projections are provided, these products represent incremental revenue opportunities in the competitive anterior spine surgery market. The integration of proprietary technology across expanding product lines demonstrates Globus Medical's commitment to innovation-driven growth in their core spine business following their merger with NuVasive.
AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches:
- COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion (ALIF) surgery, and
- Modulus™ ALIF Blades: An extension of the market-leading Modulus™ ALIF interbody spacer system.
The COHERE ™ ALIF Spacer is the latest addition to Globus Medical’s Advanced Materials Science™ (AMS) implant portfolio, featuring proprietary porous surface technology designed for bone in-growth while maintaining the imaging and mechanical properties favored in a solid PEEK interbody spacer.1,2
“Porous PEEK combines the stiffness and radiolucency of PEEK with the osseointegration potential offered by the porous technology,”1,3 said Frank Phillips, MD, professor of orthopedic surgery and fellowship director of the Division of Spine Surgery at Rush University Medical Center in Chicago. “The enhanced clinical outcomes possible with Cohere™ Porous PEEK for anterior cervical fusion4 and the comprehensive surface technology options available are now also helping to advance patient care for anterior lumbar spine surgery. In addition, the ability to radiographically assess fusion is a significant clinical benefit.”
Modulus™ ALIF Blades extend the versatility of the Modulus™ ALIF Spacer portfolio by offering surgeons different fixation options with the same interbody spacer. Procedural efficiency is achieved with Modulus™ ALIF Blades through the ability to deliver anchoring blade fixation immediately following interbody spacer placement to reduce the number of surgical steps and instruments needed in the procedure.
“Modulus™ ALIF with the anchoring blade option makes anterior spine surgery even more efficient while potentially reducing complications by reducing the number of instrument passes adjacent to major vessels,” said Anthony Kwon, MD, Orthopedic Spine Surgeon practicing at OrthoCarolina’s Spine Center and Atrium Medical Center in Charlotte, NC. “The low-profile instrumentation and streamlined delivery of fixation also helps to reduce the exposure window traditionally needed for anterior surgery, allowing for a more minimally invasive approach”.
These two new offerings strengthen Globus Medical’s comprehensive anterior spine portfolio, designed to address a variety of the most challenging procedures in spine surgery. The integration of a Porous PEEK interbody spacer option and Modulus anchor fixation demonstrate Globus Medical’s commitment to providing surgeon partners with procedurally integrated ALIF solutions.
“These products underscore our commitment to advancing surgical outcomes and providing spine surgeons with best-in-class solutions that span varying patient anatomy and surgeon preference to provide the best possible care in their hands,” said David Hole, president of Spine at Globus Medical. “We remain dedicated to delivering innovation through our product development engine to solve the unmet clinical needs of our surgeon partners while helping to improve patient care.”
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at https://www.globusmedical.com/.
References:
1. Evans NT, Torstrick FB, Lee CS, et al. High-strength, surface-porous polyether-ether-ketone for load-bearing orthopedic implants. Acta Biomater 2015;13:159-67.
2. Torstrick FB, Lin ASP, Potter D, et al. Porous PEEK improves the bone-implant interface compared to plasma-sprayed titanium coating on PEEK. Biomaterials 2018;185:106-16
3. Torstrick FB, Evans NT, Stevens HY, et al. Do surface porosity and pore size influence mechanical properties and cellular response to PEEK? Clin Orthop Relat Res 2016;474(11):2373-83.
4. Hill CP and Strenge KB. Early clinical outcomes comparing porous PEEK, smooth PEEK, and structural allograft interbody devices for anterior cervical discectomy and fusion. J Spine Neurosurg 2019;8(1):1-7.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of, and the ability of Globus Medical and NuVasive to integrate, their businesses successfully and to achieve anticipated synergies, health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
investors@globusmedical.com
Media contact:
Moran Chavez
media@globusmedical.com
FAQ
What are the key features of Globus Medical's new COHERE ALIF Spacer (GMED)?
How does the Modulus ALIF Blades system improve surgical efficiency for GMED?
What clinical benefits does the COHERE ALIF Spacer (GMED) offer to surgeons?
How do these new products enhance Globus Medical's (GMED) anterior spine portfolio?
